A subsequent analysis of PTPRD expression in both healthy and cancerous brains (GBM) and endometrial (uterine corpus endometrial carcinoma, UCEC) samples revealed a significant downregulation of the gene in the tumour cohort (Figure 3b), with a statistical significance of p < 0.01. This evidence concerns the gene PTPRD and glioblastoma.